These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1372661

  • 21. Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy.
    Neidhart JA, Mangalik A, Stidley CA, Tebich SL, Sarmiento LE, Pfile JE, Oette DH, Oldham FB.
    J Clin Oncol; 1992 Sep; 10(9):1460-9. PubMed ID: 1517789
    [Abstract] [Full Text] [Related]

  • 22. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA, Hilton S, Mazumdar M, Sadan S, Heineman M, Hirsch J, Kelly WK, Scher HI, Bajorin DF.
    J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
    [Abstract] [Full Text] [Related]

  • 23. [Dose intensity in M-VAC chemotherapy with rG-CSF for metastatic transitional urothelial cancer].
    Obata K, Kobayashi H, Takaba H, Yokoi K, Hikosaka A.
    Hinyokika Kiyo; 1994 Oct; 40(10):939-44. PubMed ID: 7527613
    [Abstract] [Full Text] [Related]

  • 24. The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
    Miyanaga N, Akaza H, Shimazui T, Ohtani M, Koiso K.
    Cancer Chemother Pharmacol; 1994 Oct; 35 Suppl():S5-8. PubMed ID: 7527735
    [Abstract] [Full Text] [Related]

  • 25. [Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
    Kuzuyama Y, Sonoda Y, Okuda T, Takashima T, Misawa S, Kashima K, Nakagawa H, Fujii H, Abe T.
    Rinsho Ketsueki; 1992 Dec; 33(12):1789-96. PubMed ID: 1282572
    [Abstract] [Full Text] [Related]

  • 26. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T, Ueoka H, Kodani T, Kamei H, Kimura I.
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [Abstract] [Full Text] [Related]

  • 27. Effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with urogenital cancer.
    Kotake T, Miki T, Akaza H, Kubota Y, Nishio Y, Matsumura Y, Ota K, Ogawa N.
    Cancer Chemother Pharmacol; 1991 Apr; 27(4):253-7. PubMed ID: 1705488
    [Abstract] [Full Text] [Related]

  • 28. [Colony stimulating factors in polychemotherapy of testicular tumors. A comparison between G-CSF and GM-CSF].
    Will R, Hofmockel G, Langer W, Frohmüller H.
    Urologe A; 1999 May; 38(3):258-63. PubMed ID: 10407985
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer.
    Kotake T, Usami M, Miki T, Togashi M, Akaza H, Kubota Y, Matsumura Y.
    Int J Urol; 1999 Feb; 6(2):61-7. PubMed ID: 10226809
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
    Neidhart J, Mangalik A, Kohler W, Stidley C, Saiki J, Duncan P, Souza L, Downing M.
    J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
    [Abstract] [Full Text] [Related]

  • 36. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.
    Eguchi K, Shinkai T, Sasaki Y, Tamura T, Ohe Y, Nakagawa K, Fukuda M, Yamada K, Kojima A, Oshita F.
    Jpn J Cancer Res; 1990 Nov; 81(11):1168-74. PubMed ID: 1702415
    [Abstract] [Full Text] [Related]

  • 37. Increase in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leukopenia.
    Watanabe Y, Kikuchi R, Kiriyama M, Nakagawa K, Oe J, Nomura H, Maruyama K, Matsumoto M.
    Biol Pharm Bull; 1995 Aug; 18(8):1084-8. PubMed ID: 8535401
    [Abstract] [Full Text] [Related]

  • 38. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
    Masuda N, Fukuoka M, Kudoh S, Kusunoki Y, Matsui K, Nakagawa K, Hirashima T, Tamanoi M, Nitta T, Yana T.
    J Clin Oncol; 1994 Jan; 12(1):90-6. PubMed ID: 7505810
    [Abstract] [Full Text] [Related]

  • 39. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Shinagawa K, Tabata M, Hirano A, Mizunuma N.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.